Now showing items 1-4 of 4
Serum kallistatin level is decreased in women with preeclampsia
Objective To evaluate the serum levels of the serine proteinase inhibitor kallistatin in women with preeclampsia (PE). Methods The clinical and laboratory parameters of 55 consecutive women with early-onset PE (EOPE) and ...
Serum catestatin level is increased in women with preeclampsia
(Taylor And Francis, 2021)
Catestatin can inhibit catecholamine release from chromaffin cells and adrenergic neurons. Catestatin can also have a strong vasodilator effect. This may be useful in understanding the pathophysiology of preeclampsia and ...
Serum vasostatin-1 level is increased in women with preeclampsia
Objective: To evaluate the serum vasostatin-1 levels in preeclamptic and non-preeclamptic pregnant women. Materials and methods: Thirty consecutive women with mild preeclampsia and sixty consecutive women with severe ...
Correction: Serum Vasostatin-1 level is increased in women with preeclampsia
(Georg Thieme Verlag Stuttgard, 2022)
No Abstract Available